Rentschler Biopharma Withdraws from Cell and Gene Field, Plans to Close UK Site
Prior to this announcement, Rentschler announced in September 2024 it would be launching an expanded service offering at its advanced therapies site in Stevenage, UK, which is now being shut down.
Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?
This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.
Cytiva and Cellular Origins Team Up on Delivering Automated CGT Manufacturing
The collaboration will combine Cytiva’s CGT manufacturing technologies with Cellular Origins' robotic manufacturing platform.
Vaccines and Virus Purification through the Ages
Learn Morewww.bio-rad.com/fluvaccine
Improving Vector Yield at Scale: A Fresh Approach to Cell Lysis Quality Assessment
Optimizing the harvest of viral particles is important for the yield and purity of the final product.
5 CDMOs to Watch in 2025
Contract development and manufacturing organizations (CDMOs) are more critical than ever as the demand for advanced therapies continues to grow.
